Sumithira Vasu
Clinical trials sponsored by Sumithira Vasu, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Triple-Target CAR T-Cells offer new hope for tough blood cancers Results expected Jul 2027 (estimated)
-
Triple-Target CAR T-Cells offer new hope for tough blood cancers
Disease control Recruiting nowThis early-stage trial tests a new type of cell therapy for people with certain blood cancers (like lymphoma, leukemia) that have returned or stopped responding to standard treatments. The therapy uses a patient's own immune cells, which are genetically modified to recognize and …
Phase 1 • Sponsor: Sumithira Vasu • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Immune cells from donors take on viruses in transplant patients
Disease control Recruiting nowThis early study tests whether immune cells from a donor can safely fight cytomegalovirus (CMV) or adenovirus (AdV) infections in people who have had a stem cell or solid organ transplant. About 20 participants will receive these virus-specific T-cells intravenously. The main goa…
Early phase 1 • Sponsor: Sumithira Vasu • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC